Expression of the p53 family in lung cancer

被引:0
作者
Uramoto, Hidetaka
Sugio, Kenji
Oyama, Tsunehiro
Nakata, Shoji
Ono, Kenji
Nozoe, Tadahiro
Yasumoto, Kosei
机构
[1] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Kitakyushu, Fukuoka 8078555, Japan
[2] Univ Occupat & Environm Hlth, Sch Med, Dept Environm Hlth, Kitakyushu, Fukuoka 8078555, Japan
关键词
p53; Delta Np73; Delta Np63; lung cancer; immunohistochemistry; prognostic factor;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: p53 is mutated in about 50% of various malignant diseases including lung cancer. The p53 family consists of p53, p 73 and p63. Although transactivating protein isoforms display p53-like functions, the Delta Np73 or Delta Np63 isoforms act toward p53 in a dominantly negative way. The aim of this study was to detect p53, Delta Np73 and Delta Np63 expressions in lung cancer and to evaluate the relationship between the expression levels of the proteins and the prognosis of patients with resectable lung cancer. Materials and Methods: Immunohistochemistry was employed to analyze the protein expression of p53, Delta Np73 and Delta Np63 in paraffin-embedded tumor samples from 132 well-characterized lung cancer patients. The correlation among the expression levels of p53, Delta Np73 and Delta Np63, clinical variables and survival outcome was analyzed. Results: Positive expressions of p53, Delta Np73 and Delta Np63 were detected in the tumor cells in 521, 77 and 44 of the 132 patients, respectively (39.4%, 58.3% and 33.3%) with lung cancer. The incidence of p53 positive expression was 54.5% and 27.6% in patients with squamous cell carcinoma and adenocarcinoma, respectively (p=0.03). The incidence of a positive expression of Delta Np73 was 64.5% and 43.6% in male and female patients, respectively (p=0.03). The incidence of Delta Np63 positive expression was 68.2% and 15.8% in the patients with squamous cell carcinoma and adenocarcinoma, respectively (p < 0.0001). The expressions of p53 and Delta Np63 were not found to significantly affect survival. However, lung cancer patients with a positived Delta Np73 expression had a poorer prognosis than those with a negative Delta Np73 expression. In addition, multivariate analysis indicated that a positive expression of Delta Np73 was a significantly independent factor for predicting a poor prognosis (p < 0.0001, risk ratio=3.38). Conclusion: Clinical evidence that the p53 family is frequently overexpressed in lung cancer specimens, especially Delta Np63 in squamous cell carcinoma, was provided. The expression of Delta Np73 may be a useful marker for predicting a poor prognosis in resectable lung cancer. Understanding how groups of lung cancer cell genes are coordinately expressed in response to physiological, immunological and micro-environmental stimuli remains an important goal. A better understanding of the gene expression profiles of tumors may help to identify molecular targets, such as Delta Np73, for effective therapy.
引用
收藏
页码:1785 / 1790
页数:6
相关论文
共 42 条
  • [1] Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients
    Casciano, I
    Mazzocco, K
    Boni, L
    Pagnan, G
    Banelli, B
    Allemanni, G
    Ponzoni, M
    Tonini, GP
    Romani, M
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (03) : 246 - 251
  • [2] COX DR, 1972, J R STAT SOC B, V34, P187
  • [3] Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance
    Dobashi, K
    Sugio, K
    Osaki, T
    Oka, T
    Yasumoto, K
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (03) : 339 - 346
  • [4] Frasca F, 2003, CANCER RES, V63, P5829
  • [5] Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer - Impact on recurrence and survival
    Gu, CD
    Osaki, T
    Oyama, T
    Inoue, M
    Kodate, M
    Dobashi, K
    Oka, T
    Yasumoto, K
    [J]. ANNALS OF SURGERY, 2002, 235 (01) : 133 - 139
  • [6] p73 independent of c-Myc represses transcription of platelet-derived growth factor β-receptor through interaction with NF-Y
    Hackzell, A
    Uramoto, H
    Izumi, H
    Kohno, K
    Funa, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39769 - 39776
  • [7] Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
    Imoto, H
    Osaki, T
    Taga, S
    Ohgami, A
    Ichiyoshi, Y
    Yasumoto, K
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (05) : 1007 - 1014
  • [8] Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337
  • [9] A lack of prognostic significance regarding ΔNp63 immunoreactivity in lung cancer
    Iwata, T
    Uramoto, H
    Sugio, K
    Fujino, Y
    Oyama, T
    Nakata, S
    Ono, K
    Morita, M
    Yasumoto, K
    [J]. LUNG CANCER, 2005, 50 (01) : 67 - 73
  • [10] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481